# Bioequivalence of Ethylenediamine Dihydrochloride Study

> **NCT01798589** · PHASE4 · COMPLETED · sponsor: **Allerderm** · enrollment: 16 (actual)

## Conditions studied

- Allergic Contact Dermatitis

## Interventions

- **DRUG:** Ethylenediamine dihydrochloride allergen patch

## Key facts

- **NCT ID:** NCT01798589
- **Lead sponsor:** Allerderm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01798589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01798589, "Bioequivalence of Ethylenediamine Dihydrochloride Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01798589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*